Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis. - Wikidata - awgldk - TriplyDB

Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis.

Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis.

http://www.wikidata.org/entity/Q38195521

about

Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription Hydroxybenzoic acid isomers and the cardiovascular system Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway.Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.Dimethyl Fumarate: A Review in Relapsing-Remitting MS.Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival.Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress.Limits in Proton Nuclear Singlet-State Lifetimes Measured with para-Hydrogen-Induced Polarization.

P2860

Q27024122-AAF0A1B0-E0DE-49FD-895E-96736A6A1F76 Q28072844-28DE01E1-A9EE-4F85-BD63-8BEF61B79678 Q28395088-09530776-F470-42FF-9AC8-3DAF7FBBA54E Q28656520-18B72B22-6355-4A29-8F0D-0FC1918BDB5D Q34667496-13BFFDBC-5592-4246-A7B3-CD3AFD47105E Q35911773-419F04CE-B047-4D4F-B7B0-19C86B9CB6CC Q38633556-436D8878-DA85-427C-A240-2228F8DC080F Q38675014-382A7154-54EC-43CB-B624-C74FC035B5ED Q38860810-E6DF37D8-C9F4-4279-9AD3-83A8D02DFB5F Q47903962-04EACFC2-D6B4-43F2-9A85-319DC70CE827 Q51230589-3D4256BE-5803-45DD-9E2A-63F62D3B16C8

P2860

Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis.

http://www.wikidata.org/entity/Q38195521

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Dimethyl fumarate: a review of ...... -remitting multiple sclerosis.

@en

type

label

Dimethyl fumarate: a review of ...... -remitting multiple sclerosis.

@en

prefLabel

Dimethyl fumarate: a review of ...... -remitting multiple sclerosis.

@en

P1433

Q38195521-78AA029F-A424-46DB-849B-79825722970C

P1476

Q38195521-D439AD38-6B57-48A1-AAFA-4870B56DA90B

P2093

Q38195521-0EB1B65D-0B8B-4490-8F3E-88483DCC4CB1

Q38195521-A0303C02-75CD-4FC6-970C-40EEA28F5593

P2860

Q38195521-0EE6A9D0-1437-4C62-94E0-0242D14DE8DE

Q38195521-13EA707A-6AA0-435D-B88E-5D3E97AEA6CA

Q38195521-15D60CC9-6BE0-41F4-9893-039C238E6B25

Q38195521-1C889A87-0D1C-4F96-9ABB-3B4836F4525B

Q38195521-23C50B41-F287-44D1-8A30-E3BBE42071A4

Q38195521-269C02E8-2EFF-4477-A3FE-E00168EA97D0

Q38195521-4A39DBDF-AB79-4037-A8EA-73FCC36636C5

Q38195521-4DA18AD0-FE0A-410A-97D3-FEB72B142F3F

Q38195521-59D8AC14-0A6E-46EF-946D-04282BBD76F7

Q38195521-5A3916B2-203C-4454-B8CD-098292BDD81E

P2888

Q38195521-3D48D688-4D45-4963-8FEA-5E822D4B6017

P304

Q38195521-3349B4D7-CE1A-4171-A7A0-FC7489155D7B

P31

Q38195521-06B878AE-20D4-4AB8-B5B0-535A5CEB759A

P356

Q38195521-D03AF5FC-6699-42A8-AAAF-3F927E56AA49

P433

Q38195521-311C5F7F-3240-4EBC-B1E7-119C7A8143ED

P478

Q38195521-89DB6EDA-8788-4B60-B0B7-3B9F8833C1CE

P577

Q38195521-1BF466CA-4FC8-4E62-81BD-1F7F26ED26B6

P698

Q38195521-8F4ACB36-B84F-4B44-85B3-625DE3A1B15A

P921

Q38195521-C50E28E7-84FC-4D1D-AFDF-50C08F75CCF1

P356

S40263-014-0155-5

P1433

P1476

Dimethyl fumarate: a review of ...... -remitting multiple sclerosis.

@en

P2093

Celeste B Burness

http://www.w3.org/2001/XMLSchema#string

Emma D Deeks

http://www.w3.org/2001/XMLSchema#string

P2860

Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

Multiple sclerosis

The role of magnetic resonance techniques in understanding and managing multiple sclerosis.

Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.

Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.

P2888

s40263-014-0155-5

P304

373-387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40263-014-0155-5

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24623127

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis